Dr Lucio D’Anna obtained his MD with Honours at the Medical School of the University of Udine, Italy and then he completed his Neurology training with Honours.
Early symptoms include difficulty in remembering recent conversations, names or events, apathy and depression. Later symptoms include impaired communication, disorientation, confusion, poor judgement, behaviour changes and ultimately difficult speaking, swallowing and walking.
Dementech Neurosciences offers a wide range of cutting-edge services, specifically designed for people with AD, such as the Dementech Biomaker Tools and genetic counselling appointments. By using the latest advances in imaging and genetics, we are able to answer all your questions regarding the diagnosis, prognosis, monitoring progression and response to treatment.
At Dementech Neurosciences, we offer a multidisciplinary approach to treat all the variety of symptoms of AD. We have in-house speech and language therapist, occupational therapist, dietitian, psychologist and psychiatrist to manage effectively HD symptoms and complications. At Dementech Neurosciences we use cutting-edge technology CANTAB to assess the severity of cognitive deficits in people with AD. This enables us to provide an early diagnosis of cognitive impairment and effectively manage it. We also provide genetic screening and counselling for the family carrying genes associated with an altered risk of AD. Moreover, we offer the opportunity to participate in clinical trials testing novel pharmacological intervention, before they become available to the public, aiming to delay the progression of the disease.